Sign In
Buy ARR
$16.55
-0.210 (-1.25%)
At Close: Jun 22, 2026
New Strong Sell Stocks for June 23rd
06:16am, Tuesday, 23'rd Jun 2026
ARR, AMTB and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on June 23rd, 2026.
Similarweb Secures Multi-Year, Seven-Figure ARR Contracts Worth Approximately $47 Million in Total Contract Value
08:00am, Monday, 15'th Jun 2026
TEL AVIV, Israel--(BUSINESS WIRE)--Similarweb Ltd. (NYSE: SMWB), a leading digital data and analytics company powering critical business decisions, today announced that it has surpassed $300 million i
Cellebrite: Stronger Fundamentals Support A Buy Rating
11:41am, Friday, 12'th Jun 2026
Cellebrite (CLBT) remains a buy as fundamentals strengthen, with FedRAMP High achieved and federal demand reaccelerating. Q2 ARR guidance of $510–513M implies 22–23% growth, supporting a narrative
OpenAI: Mega IPO Faces Anthropic Claude Mythos Reckoning
09:00am, Wednesday, 10'th Jun 2026
OpenAI confidentially filed for IPO amid intensifying competition from Anthropic, which now leads in ARR run rate and coding capabilities. Anthropic's Claude Fable 5 and Mythos 5 launches have signifi
Docusign Declines 7.2% Since Beating Q1 Earnings & Revenue Estimates
09:56am, Monday, 08'th Jun 2026
DOCU tops Q1 fiscal 2027 earnings and revenue estimates as IAM adoption accelerates, profitability improves and ARR growth confidence strengthens.
Baron Discovery Fund Q1 2026: Who Moved The Needle
01:35am, Monday, 08'th Jun 2026
In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing the Russell 2000 Growth Index by 7.84% due to significant underperformance in the software sector. A
Buy 6 June Dividend Power Dogs
06:24am, Saturday, 06'th Jun 2026
Dividend Power strategy targets 35 high-yield, low-valuation stocks, with six 'safer' picks showing free cash flow yields exceeding dividend yields. Top ten Dividend Power stocks project average net g
Palo Alto Networks: The Market Is Pricing 2030 At 12x
12:04pm, Friday, 05'th Jun 2026
Palo Alto Networks is a long-term Buy, supported by 28% organic NGS ARR growth and robust AI-driven portfolio expansion. NGS ARR headline growth (+60%) is acquisition-boosted; organic growth is 28%, w
DocuSign Reports Q1 Results: Focus on IAM and Financial Outlook
11:14am, Friday, 05'th Jun 2026
DocuSign (DOCU) experienced a decline of 5% in trading following its Q1 report for April. While the results showed solid growth, the revenue guidance for Q2 (J
Alkami Technology Touts $500M ARR, AI Upside and Bank Demand at Fintech Event
04:03pm, Tuesday, 02'nd Jun 2026
Alkami Technology NASDAQ: ALKT executives outlined the company's growth strategy, financial outlook and market positioning during a William Blair fintech and payments event, emphasizing demand from re
RYBREVANT FASPRO⢠(amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where
RYBREVANTÂ (amivantamab-vmjw) plus LAZCLUZEÂ (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR
UiPath Q1 Earnings In Line With Estimates, Revenues Increase Y/Y
01:26pm, Friday, 29'th May 2026
PATH tops Q1 FY27 estimates as AI-driven automation demand boosts ARR growth, enterprise expansion deals and profitability gains.
MongoDB (MDB) Posts Strong Q1 Earnings Driven by Cloud Adoption and AI Momentum
11:14am, Friday, 29'th May 2026
MongoDB (MDB) has seen its stock rise following a robust Q1 earnings report, although shares have retreated from an initial surge of over 20% in after-hours tra
The Smartest AI Money Is Buying Nebius
03:54am, Friday, 29'th May 2026
Leopold Aschenbrenner disclosed a 5.6% stake after Microsoft, Meta, and Nvidia validated Nebius operationally and financially. Q1 revenue surged 684% YoY to $399 million, while Nebius AI EBITDA margin
